It is intriguing to speculate that this result in blood cells is similar to reports that show SMN decreases through development in brain and spinal cord tissues in SMA model mice, since this relationship would support use of PBMCs as a surrogate tissue for SMN upregulation drug trials [37], [40]. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.